300244200076

The barcode 300244200076 corresponds to the product Uroxatral Extended-Release Tablets, manufactured by Bayer Corporation/Consumer Care Div. Uroxatral is an alpha-blocker medication used to treat benign prostatic hyperplasia (BPH) and symptoms of an enlarged prostate.

According to the FDA, Uroxatral is available in tablet form with a recommended dosage of 10mg or 20mg once daily. The product is classified as a prescription medication and is typically prescribed for short-term treatment of BPH symptoms.

There are no significant price variations for Uroxatral Extended-Release Tablets among different retailers, but prices can vary depending on location, pharmacy, and availability. On average, the wholesale price of 30 tablets of Uroxatral 10mg/20mg is around $100-$150 USD. However, retail prices may be higher.

Health-related concerns associated with Uroxatral include:

1. Postural hypotension: Uroxatral can cause a sudden drop in blood pressure, leading to dizziness or fainting.
2. Increased risk of priapism: Alpha-blockers like Uroxatral can increase the risk of prolonged erections, which may be painful and require medical attention.
3. Allergic reactions: Some patients may experience allergic reactions, such as hives, itching, or difficulty breathing.

It is essential to follow the recommended dosage and consult with a healthcare professional if any side effects occur.

There are no specific warnings or cautions for Uroxatral in terms of barcode-specific disclaimers. However, as a consumable product, there may be general health-related disclaimers on the packaging, such as:

• "Use as directed by your doctor."
• "Do not take more than prescribed by your doctor."
• "If you experience any side effects, contact your doctor or pharmacist immediately."

Please note that this information is based on publicly available data and may not reflect the most up-to-date information. It's always best to consult with a healthcare professional for personalized advice on medication use and potential risks associated with Uroxatral Extended-Release Tablets.